title: Delayed cytotoxicity of 6-mercaptopurine is compatible with mitotic death caused by DNA damage due to incorporation of 6-thioguanine into DNA as 6-thioguanine nucleotide.
abstract: Many protocol studies have shown that low dose 6-mercaptopurine (6MP) in maintenance chemotherapy for childhood acute lymphoblastic leukemia (ALL) can be utilized to cure the disease. Mitotic or reproductive cell death has been recognized after G2 arrest when cells are treated with antitumor agents. The precise mechanism of mode of action of 6MP still remains unclear. We found delayed cytotoxic effect of 6MP in P388 murine leukemic cells. Morphological study showed that 6MP induced delayed death was characterized by an enlargement of cell size and multinucleated nuclei. Agarose gel electrophoresis of fragmented DNA from cells treated with 6MP showed the typical ladder pattern. These findings were compatible with mitotic death. Our results make us hypothesize that the delayed cytotoxicity of 6MP is one of the drug induced mitotic deaths caused by DNA damage due to incorporation of 6-thioguanine (6TG) into DNA as thioguanine nucleotide (TGN). Mitotic death may be a mechanism for killing the cycling cells from residual leukemic cells in G0 or long G1 phases in the treatment of childhood ALL.
authors.affiliation: Dept. of Pediatrics, Mie University School of Medicine, Tsu-city, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Inamochi
authors.forename: M
authors.initials: M
authors.lastname: Higashigawa
authors.forename: Y
authors.initials: Y
authors.lastname: Shimono
authors.forename: T
authors.initials: T
authors.lastname: Nagata
authors.forename: D C
authors.initials: DC
authors.lastname: Cao
authors.forename: X Y
authors.initials: XY
authors.lastname: Mao
authors.forename: T
authors.initials: T
authors.lastname: M'soka
authors.forename: H
authors.initials: H
authors.lastname: Hori
authors.forename: H
authors.initials: H
authors.lastname: Kawasaki
authors.forename: M
authors.initials: M
authors.lastname: Sakurai
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D004249:DNA Damage; D004261:DNA Replication / Q000187:drug effects; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000737:chemistry; D007942:Leukemia, Experimental / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D015122:Mercaptopurine / Q000494:pharmacology*; D051379:Mice; D008938:Mitosis / Q000187:drug effects*; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology*; D012334:RNA, Neoplasm / Q000096:biosynthesis / Q000737:chemistry; D013866:Thioguanine / Q000737:chemistry*; D014410:Tumor Stem Cell Assay
chemical_list: D000964:Antimetabolites, Antineoplastic; D004273:DNA, Neoplasm; D019384:Nucleic Acid Synthesis Inhibitors; D012334:RNA, Neoplasm; D015122:Mercaptopurine; D013866:Thioguanine